| Product Code: ETC7623288 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Antimicrobial Resistance Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Ireland Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Ireland Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Ireland Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Ireland Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Ireland Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Ireland Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Ireland |
4.2.2 Growing awareness about the impact of antimicrobial resistance on public health |
4.2.3 Investments in research and development for new antimicrobial drugs |
4.3 Market Restraints |
4.3.1 Strict regulatory environment for antimicrobial drugs |
4.3.2 Lack of effective antibiotic stewardship programs |
4.3.3 Limited availability of new treatment options for resistant infections |
5 Ireland Antimicrobial Resistance Market Trends |
6 Ireland Antimicrobial Resistance Market, By Types |
6.1 Ireland Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Ireland Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Ireland Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Ireland Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Ireland Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Ireland Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Ireland Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Ireland Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Ireland Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Ireland Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Ireland Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Ireland Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Ireland Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Ireland Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Ireland Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Ireland Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Ireland Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Ireland Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Ireland Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Ireland Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Ireland Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Ireland Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Ireland Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Ireland Antimicrobial Resistance Market Export to Major Countries |
7.2 Ireland Antimicrobial Resistance Market Imports from Major Countries |
8 Ireland Antimicrobial Resistance Market Key Performance Indicators |
8.1 Rate of antimicrobial-resistant infections in Ireland |
8.2 Percentage of healthcare facilities implementing antimicrobial stewardship programs |
8.3 Number of new antimicrobial drugs in development in Ireland |
9 Ireland Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Ireland Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Ireland Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Ireland Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Ireland Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Ireland Antimicrobial Resistance Market - Competitive Landscape |
10.1 Ireland Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Ireland Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here